Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06530550
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-28
Brief Title:
PI3K Inhibitors for the Treatment of RelapsedRefractory Indolent TNK-cell Lymphomas
Sponsor:
Organization:
None